Medical Communications

AstraZeneca is set to sell the rights to its AT1 subtype angiotensin II receptor antagonist Atacand (candesartan cilexetil) and Atacand …

The European Commission has approved GlaxoSmithKline’s Zeljula as a first line monotherapy maintenance treatment for adult patients with ovarian cancer …

The Eat Out to Help Out scheme contributed to a significant rise in new coronavirus cases according to a study …

The top ten news stories this week focus on COVID-19 studies, as new research has found that over 80% of …

New guidance from the National Institute of Health and Care Excellence says that women with womb cancer should be tested …

The latest monthly edition of Pharmafocus is available to read for free online now!

Thirteen-year-old Calvin Muir lives with the ultra-rare genetic condition Timothy syndrome. Like many parents of rare disease patients, his mother …

IBM has partnered with Pfizer to design an artificial intelligence model to predict the eventual onset of neurological diseases – …

The FDA has approved Gilead’s antiviral therapy Veklury (remdesivir) for the treatment of hospitalised COVID-19 patients, making it the first …

NICE has given its recommendation to Bayer’s androgen receptor inhibitor Nubeqa (darolutamide) in combination with androgen deprivation therapy (ADT) for …

Computer system validation can often take months to complete. It typically involves infrastructure qualification (IQ), operational qualification (OQ), and performance …

The top ten news stories this week focus on coronavirus research, with the UK is set to be the first …

Sanofi’s Sarclisa (isatuximab) has secured a recommendation from NICE for routine use on the NHS in England and Wales as …

Gilead’s antiviral therapy remdesivir has emerged as one of the most promising drugs to treat COVID-19 infections, but recent studies …

A five-year-old girl had died while taking part in Lysogene’s clinical trial investigating its gene therapy. The child was suffering …